Search bioRxivSearch

bioRxiv · 10.1101/663989

Neurally-constrained modeling of human gaze strategies in a change blindness task

Abstract

Visual attention enables us to engage selectively with the most important events in the world around us. Yet, sometimes, we fail to notice salient events. \"Change blindness\" - the surprising inability to detect and identify salient changes that occur in flashing visual images - enables measuring such failures in a laboratory setting. We discovered that human participants (n=39) varied widely (by two-fold) in their ability to detect changes when tested on a laboratory change blindness task. To understand the reasons for these differences in change detection abilities, we characterized eye-movement patterns and gaze strategies as participants scanned these images. Surprisingly, we found no systematic differences between scan paths, fixation maps or saccade patterns between participants who were successful at detecting changes, versus those who were not. Yet, two low-level gaze metrics - the mean fixation duration and the variance of saccade amplitudes - systematically predicted change detection success. To explain the mechanism by which these gaze metrics could influence performance, we developed a neurally constrained model, based on the Bayesian framework of sequential probability ratio testing (SPRT), which simulated gaze strategies of successful and unsuccessful observers. The models ability to detect changes varied systematically with mean fixation duration and saccade amplitude variance, closely mimicking observations in the human data. Moreover, the models success rates correlated robustly with human observers success rates, across images. Our model explains putative human attention mechanisms during change blindness tasks and provides key insights into effective strategies for shifting gaze and attention for artificial agents navigating dynamic, crowded environments.\n\nAuthor SummaryOur brain has the remarkable capacity to pay attention, selectively, to the most important events in the world around us. Yet, sometimes, we fail spectacularly to notice even the most salient events. We tested this phenomenon in the laboratory with a change-blindness experiment, by having participants freely scan and detect changes across discontinuous image pairs. Participants varied widely in their ability to detect these changes. Surprisingly, their success correlated with differences in low-level gaze metrics. A Bayesian model of eye movements, which incorporated neural constraints on stimulus encoding, could explain the reason for these differences, and closely mimicked human performance in this change blindness task. The models gaze strategies provide relevant insights for artificial, neuromorphic agents navigating dynamic, crowded environments.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jagatap, A., Jain, H., Purokayastha, S., Sridharan, D.. 2019-06-09. Neurally-constrained modeling of human gaze strategies in a change blindness task. https://doi.org/10.1101/663989

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience